Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RXRB | P28702 | 8/20 | 0.38 |
| ▸ | RXRA | P19793 | 7/20 | 0.38 |
| ▸ | RXRG | P48443 | 4/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22853058 | 0.96 | KDM4E (0.47) | KDM4EGAAMAPTRXRBRXRA | |
| SCHEMBL22853056 | 0.81 | KDM4E (0.52) | KDM4EGAAMAPTRXRBRXRA | |
| SCHEMBL16940870 | 0.78 | MEN1 (0.44) | KDM4EMAPTPOLB | |
| SCHEMBL23928340 | 0.78 | RXRB (0.53) | KDM4EGAAMAPTRXRBRXRA | |
| SCHEMBL23959627 | 0.78 | RXRB (0.53) | KDM4EGAAMAPTRXRBRXRA | |
| SCHEMBL23928344 | 0.78 | MEN1 (0.47) | KDM4EGAAMAPTRXRBRXRA | |
| SCHEMBL23959743 | 0.78 | CYP1A1 (0.44) | KDM4EGAAMAPTRXRBRXRA | |
| SCHEMBL26230931 | 0.78 | GABRA1 (0.55) | KDM4EGAAMAPTRXRBRXRA | |
| SCHEMBL23729372 | 0.77 | RXRB (0.51) | KDM4EGAAMAPTRXRBRXRA | |
| SCHEMBL23959632 | 0.77 | RXRB (0.51) | KDM4EGAAMAPTRXRBRXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210336151-A1 | Light-Emitting Device Material, Electron-Transport Layer Material, Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210336151-A1 | Light-Emitting Device Material, Electron-Transport Layer Material, Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device | SPIN3, SLC39A3, SKIC3 | KDM4E 4238/4885GAA 4247/4885MAPT 1456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.